Clinical Trial Update: Study In Healthy Subjects To Evaluate The Photo-Irritant Potential Of Eltrombopag [Phase 1]

View source ↗

Summary

Phase 1 study in healthy subjects to assess the photo-irritant potential of eltrombopag.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Thrombocytopenic Purpura

Drugs mentioned

• Eltrombopag (eltrombopag)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Purpura, Thrombocytopaenic, Idiopathic | Phase 1 | Status: COMPLETED